The Use of Animal Models for Cancer Chemoprevention Drug Development

Moon, 1989, Chemoprevention of experimental carcinogenesis in animals, Prev Med, 18, 576, 10.1016/0091-7435(89)90031-5 Russo, 1998, Biological and molecular basis of human breast cancer, Front Biosci, 3, D944, 10.2741/A335 Lubet, 1998, Chemopreventive effects of the aromatase inhibitor vorozole (R83842) in the methylnitrosourea-induced mammary cancer model, Carcinogenesis, 19, 1345, 10.1093/carcin/19.8.1345 Lubet, 1994, Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU) - induced mammary tumor model in Sprague-Dawley rats, Carcinogenesis, 15, 2775, 10.1093/carcin/15.12.2775 Christov, 2000, Cellular responses of mammary carcinomas to aromatase inhibitors: effects of vorozole, Breast Cancer Res Treat, 60, 117, 10.1023/A:1006384026252 Baum, 2003, Cancer, 98, 1802, 10.1002/cncr.11745 Moon, 1992, Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen, Anticancer Res, 12, 1147 McCormick, 1982, Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl) retinamide and ovarectomy, Cancer Res, 42, 508 Moon, 1994, Chemoprevention of MNU-induced mammary tumorigenesis by hormone modifying agents: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone, Anticancer Res, 14, 889 Moon, 1976, Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis by retinyl acetate, Cancer Res, 36, 2626 Grubbs, 1995, Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol, Anticancer Res, 15, 709 Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, 98, 10869, 10.1073/pnas.191367098 Xu, 1999, Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation, Nat Genet, 22, 37, 10.1038/8743 Rottenberg, 2008, High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs, Proc Natl Acad Sci U S A, 105, 17079, 10.1073/pnas.0806092105 Green, 2001, 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice, Cancer Res, 61, 7449 Herschkowitz, 2007, Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors, Genome Biol, 8, R76, 10.1186/gb-2007-8-5-r76 Lubet, 2009, Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis, Cancer Prev Res, 2, 161, 10.1158/1940-6207.CAPR-08-0134 Grubbs, 2006, Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers, Carcinogenesis, 27, 1232, 10.1093/carcin/bgi308 Lubet, 2006, Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations, Mol Cancer Ther, 5, 1073, 10.1158/1535-7163.MCT-05-0398 Lubet, 2005, Efficacy of targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis, Carcinogenesis, 26, 441, 10.1093/carcin/bgh338 Jones, 2009, The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer, Breast Cancer Res Treat, 116, 10.1007/s10549-008-0081-7 Wattenberg, 1997, Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice, Cancer Res, 57, 5489 Wattenberg, 2000, Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol, Carcinogenesis, 21, 179, 10.1093/carcin/21.2.179 Yao, 2004, Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions, Oncogene, 23, 7746, 10.1038/sj.onc.1207985 Zhang, 2004, Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models, Oncogene, 23, 3841, 10.1038/sj.onc.1207496 Zhang, 2003, Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf, Oncogene, 22, 6257, 10.1038/sj.onc.1206630 Moon, 1994, Chemoprevention of respiratory tract neoplasia in the hamster by oltipraz, alone and in combination, Int J Oncol, 4, 661 Wattenberg, 2004, Chemoprevention of cancer of the upper respiratory tract of the Syrian Golden hamster by aerosol administration of difluoromethylornithine and 5-fluorouracil, Cancer Res, 64, 2347, 10.1158/0008-5472.CAN-03-4032 Wang, 2004, A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility, Cancer Res, 64, 1647, 10.1158/0008-5472.CAN-03-3273 Hecht, 1980, Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N′-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, Cancer Res, 40, 298 Castonguay, 1991, Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies, Exp Lung Res, 17, 485, 10.3109/01902149109064434 Conway, 1998, Chemopreventive potential of fumaric acid, N-acetyl-l-cysteine, N-(4-hydroxyphenyl) retinamide, and β-carotene for tobacco nitrosamine induced lung tumors in A/J mice, Cancer Lett, 24, 85, 10.1016/S0304-3835(97)00454-0 Gunning, 2000, Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice, Exp Lung Res, 26, 757, 10.1080/01902140150216800 Balansky, 2007, Potent carcinogenicity of cigarette smoke in mice exposed early in life, Carcinogenesis, 28, 2236, 10.1093/carcin/bgm122 Balansky, 2010, Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine, Int J Cancer, 126, 1047 Calbó, 2005, Genotype-phenotype relationships in a mouse model for human small-cell lung cancer, Cold Spring Harb Symp Quant Biol, 70, 225, 10.1101/sqb.2005.70.026 Rao, 2006, Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets, Mol Cancer Ther, 5, 1530, 10.1158/1535-7163.MCT-06-0061 Reddy, 2006, Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats, Cancer Res, 66, 4542, 10.1158/0008-5472.CAN-05-4428 Raju, 2005, Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence, Int J Cancer, 113, 798, 10.1002/ijc.20640 Steele, 2002, Correlation between electron-donating ability of a series of 3-nitroflavones and their efficacy to inhibit the onset and progression of aberrant crypt foci in the rat colon, Cancer Res, 62, 6506 Jacoby, 2000, The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis, Cancer Res, 60, 5040 Reddy, 1999, Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process, Cancer Res, 59, 3387 Bertagnolli, 2006, celecoxib for the prevention of sporadic colorectal adenomas, N Engl J Med, 355, 874, 10.1056/NEJMoa061355 Arber, 2006, Celecoxib for the prevention of colorectal adenomatous polyps, N Engl J Med, 355, 885, 10.1056/NEJMoa061652 Li, 1999, Prevention by aspirin and its combination with α-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon, Carcinogenesis, 20, 425, 10.1093/carcin/20.3.425 Gann, 1993, Low-dose aspirin and incidence of colorectal tumors in a randomized trial, J Natl Cancer Inst, 85, 1220, 10.1093/jnci/85.15.1220 Cook, 2005, Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial, JAMA, 294, 47, 10.1001/jama.294.1.47 Steele, 2009, Chemopreventive efficacy of naproxen and NO-naproxen in rodent models of colon and urinary bladder, and mammary cancer, Cancer Prev Res, 2, 951, 10.1158/1940-6207.CAPR-09-0080 Jacoby, 2004, Ursodeoxycholate/sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis, Gastroenterology, 127, 838, 10.1053/j.gastro.2004.06.003 Williams, 2004, NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice, Biochem Biophys Res Commun, 313, 784, 10.1016/j.bbrc.2003.12.015 Swamy, 2006, Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice, Cancer Res, 66, 7370, 10.1158/0008-5472.CAN-05-4619 Grubbs, 2000, Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancer in male B6D2F1 mice and female F344 rats, Cancer Res, 60, 5599 Yao, 2004, Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine, Neoplasia, 6, 569, 10.1593/neo.04223 Lubet, 2005, 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin, Carcinogenesis, 26, 571, 10.1093/carcin/bgh352 Bosland, 1983, Adenocarcinomas of the prostate induced by N-nitroso-N-methylurea in rats pretreated with cyproterone acetate and testosterone, Cancer Lett, 18, 69, 10.1016/0304-3835(83)90119-2 McCormick, 2007, Null effect of dietary restriction on prostate carcinogenesis in the Wistar-Unilever rat, Nutr Cancer, 57, 194, 10.1080/01635580701277494 McCormick, 2007, Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone, Carcinogenesis, 28, 398, 10.1093/carcin/bgl141 Green, 2001, 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice, Cancer Res, 61, 7449 Ma, 2005, Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis, Cancer Res, 65, 5730, 10.1158/0008-5472.CAN-04-4519 McCormick, 1986, Antipromotional activity of dietary N-(4-hydroxyphenyl)retinamide in two-stage skin tumorigenesis in CD-1 and SENCAR mice, Cancer Lett, 31, 133, 10.1016/0304-3835(86)90003-0 Warren, 1993, Mechanisms of inhibition of tumor progression, Basic Life Sci, 61, 279 DiGiovanni, 1992, Multistage carcinogenesis in mouse skin, Pharmacol Ther, 54, 63, 10.1016/0163-7258(92)90051-Z Poel, 1959, Effect of carcinogen dosage and duration of exposure on skin-tumor induction in mice, J Natl Cancer Inst, 22, 19 Burke, 2000, Effects of topical and oral vitamin E on pigmentation and skin cancer induced by ultraviolet irradiation in Skh:2 hairless mice, Nutr Cancer, 38, 87, 10.1207/S15327914NC381_13 Fischer, 1999, Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis, Mol Carcinog, 25, 231, 10.1002/(SICI)1098-2744(199908)25:4<231::AID-MC1>3.0.CO;2-F Lu, 2001, Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat, Cancer Res, 61, 5002 Fischer, 2003, Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice, Carcinogenesis, 24, 945, 10.1093/carcin/bgg046 Fischer, 2001, Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice, Carcinogenesis, 22, 83, 10.1093/carcin/22.1.83 Athar, 2006, Hedgehog signaling in skin development and cancer, Exp Dermatol, 15, 667, 10.1111/j.1600-0625.2006.00473.x So, 2004, Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/− mice exposed to ultraviolet or ionizing radiation, Cancer Res, 64, 4385, 10.1158/0008-5472.CAN-03-1927 Crist, 2005, Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture, Carcinogenesis, 26, 951, 10.1093/carcin/bgi039 Xing, 2006, A mouse model for the molecular characterization of Brca1-associated ovarian carcinoma, Cancer Res, 66, 8949, 10.1158/0008-5472.CAN-06-1495 Hakim, 2009, Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu, Cancer Prev Res, 2, 114, 10.1158/1940-6207.CAPR-08-0065 Wax, 2005, Prospective grading of neoplastic change in rat esophagus using angle-resolve low coherance interferometry, J Biomed Optics, 10, 10.1117/1.2102767 Chen, 2004, Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis, Clin Cancer Res, 10, 6703, 10.1158/1078-0432.CCR-04-0838 Chen, 2002, Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model, Carcinogenesis, 23, 2095, 10.1093/carcin/23.12.2095 Vaughan, 2005, Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study, Lancet Oncol, 6, 945, 10.1016/S1470-2045(05)70431-9 Opitz, 2002, A mouse model of human oral-esophageal cancer, J. Clin Invest, 110, 761, 10.1172/JCI0215324 Ohne, 1981, Induction of squamous cell carcinoma in the oral cavity of rats by oral administration of 4-nitroquinoline-1-oxide (4NQO) in drinking water, Bull Tokyo Dent Coll, 22, 85 Ohne, 1985, Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking water, Oral Surg Oral Med Oral Pathol, 59, 600, 10.1016/0030-4220(85)90189-6 Gerson, 1990, Oral cancer, Crit Rev Oral Biol Med, 1, 153, 10.1177/10454411900010030101 McCormick, 2010, Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and non-selective COX Inhibitors, Cancer Prev Res, 3, 73, 10.1158/1940-6207.CAPR-09-0151 Ouyang, 2006, Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model, Cancer Res, 66, 4503, 10.1158/0008-5472.CAN-05-3118 Freedman, 1993, : Statistical analysis of animal cancer chemoprevention experiments, Biometrics, 49, 259, 10.2307/2532621